Salarius Pharmaceuticals (NASDAQ: SLRX) completed its merger with Decoy Therapeutics, combining the companies to focus on advancing Decoy's peptide conjugate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE